Category: AIDS, HIV & STDs
AIDS, HIV & STDs market research reports by GlobalData
-
Gonorrhea (GN): Competitive Landscape
Gonorrhea (GN): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Gonorrhea therapeutics. In 2024, more than 3.7 million diagnosed incident cases of GN are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More
-
HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments ... Read More
-
Genital Herpes: Competitive Landscape
Genital Herpes: Competitive Landscape Genital Herpes: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in genital herpes therapeutics. In 2024, more than 52 million diagnosed prevalent cases of HSV-2 infection are anticipated ... Read More
-
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of D ... Read More
-
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 Summary Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize qu ... Read More
-
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regul ... Read More
-
Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provid ... Read More
-
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of D ... Read More
-
Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulat ... Read More
-
Human Immunodeficiency Virus (HIV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
Human Immunodeficiency Virus (HIV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Human Immunodeficiency Virus (HIV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend ... Read More
-
Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spons ... Read More
-
Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End P ... Read More
-
Human Immunodeficiency Virus (HIV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
Human Immunodeficiency Virus (HIV) Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostics) - Global Market Analysis and Fore ... Read More
-
Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Gonorrhea Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, ... Read More
-
Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Human Immunodeficiency Virus (HIV) Point of Care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “HIV Point of care (POC) Tests Pipeline Report including St ... Read More
-
Human Immunodeficiency Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030
Human Immunodeficiency Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 Summary Human Immunodeficiency Virus Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Re ... Read More
-
Digital Marketing Trends in Human Immunodeficiency Virus (HIV)
Digital Marketing Trends in Human Immunodeficiency Virus (HIV) Summary Gilead’s Biktarvy.com achieved the highest traffic across branded HIV patient sites in the US from April 2021 to March 2022, with about 3,800,000 visits, followed by ViiV's Dovato.com and Gilead’s Descovy.com. The highest proport ... Read More
Research Assistance
